Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED95 Dose of Remimazolam Tosilate for General Anesthesia Induction in Elderly Patients
ChiCTR2100048137Phase 4Not yet recruiting
- Sponsor
- Renmin Hospital of Wuhan University
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam, sponsored by Renmin Hospital of Wuhan University. Primary endpoint: success rate of sedation. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2100048137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048137.